Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
To view a copy of this licence, visit About this article Cite this article Wu, X., Cen, Q., Lin, X
Measures total body fat percentage, segmental muscle mass, visceral fat area in square centimeters, and hydration status
GLP-1 medications have already changed whats possible in medical weight loss
Thats a decrease of over 60%a steep decline by any measure
OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship
They sent it immediately
US$ 29.43
US$ 26.42
US$ 25.76
